The genus Oenanthe L. (Apiaceae) comprises aquatic and semi-aquatic perennial plants widely distributed across temperate regions of the Northern Hemisphere. These species display a marked botanical and pharmacological dualism: while Oenanthe javanica (Blume) DC. is widely cultivated as an edible vegetable and traditional remedy in East Asia, species such as Oenanthe crocata L. rank among the most toxic European flora due to lethal C17-polyacetylenes, such as oenanthotoxin. Following PRISMA 2020 guidelines across PubMed, Scopus, and Web of Science databases, this systematic review maps the botanical, phytochemical, and bioactive landscape of the genus. Phytochemical profiling highlights a complex secondary metabolome. This includes volatile essential oils (chemotypes rich in monoterpenes like γ-terpinene, β-pinene, p-cymene, and ocimene, or phenylpropanoids such as dill apiol) and phenolics (chlorogenic, caffeic, and feruloylquinic acids; flavonols such as rutin, persicarin, and isorhamnetin-3-O-galactoside), alongside furanocoumarins, lignans, and polysaccharides (OJP-2). Biological and pharmacological screenings demonstrate broad-spectrum bioactivities, including antioxidant and anti-inflammatory activity via NF-κB, MAPK, and NLRP3 inflammasome suppression, anti-HBV antiviral efficacy, antiplatelet and cardioprotective mechanisms, hepatoprotection against alcohol- and diet-induced steatohepatitis, endovascular protection in severe sepsis, skin anti-aging enzyme inhibition (elastase/hyaluronidase), and selective cytotoxicity. Ultimately, this review establishes a comprehensive baseline for the pharmaceutical and nutraceutical valorization of Oenanthe species while defining critical boundaries regarding their toxicological risks.
Mapping the Botanical, Phytochemical, and Bioactive Landscape of the Genus Oenanthe L. (Apiaceae)
Mariangela Marrelli
;Filomena Conforti
;Giancarlo Statti
2026-01-01
Abstract
The genus Oenanthe L. (Apiaceae) comprises aquatic and semi-aquatic perennial plants widely distributed across temperate regions of the Northern Hemisphere. These species display a marked botanical and pharmacological dualism: while Oenanthe javanica (Blume) DC. is widely cultivated as an edible vegetable and traditional remedy in East Asia, species such as Oenanthe crocata L. rank among the most toxic European flora due to lethal C17-polyacetylenes, such as oenanthotoxin. Following PRISMA 2020 guidelines across PubMed, Scopus, and Web of Science databases, this systematic review maps the botanical, phytochemical, and bioactive landscape of the genus. Phytochemical profiling highlights a complex secondary metabolome. This includes volatile essential oils (chemotypes rich in monoterpenes like γ-terpinene, β-pinene, p-cymene, and ocimene, or phenylpropanoids such as dill apiol) and phenolics (chlorogenic, caffeic, and feruloylquinic acids; flavonols such as rutin, persicarin, and isorhamnetin-3-O-galactoside), alongside furanocoumarins, lignans, and polysaccharides (OJP-2). Biological and pharmacological screenings demonstrate broad-spectrum bioactivities, including antioxidant and anti-inflammatory activity via NF-κB, MAPK, and NLRP3 inflammasome suppression, anti-HBV antiviral efficacy, antiplatelet and cardioprotective mechanisms, hepatoprotection against alcohol- and diet-induced steatohepatitis, endovascular protection in severe sepsis, skin anti-aging enzyme inhibition (elastase/hyaluronidase), and selective cytotoxicity. Ultimately, this review establishes a comprehensive baseline for the pharmaceutical and nutraceutical valorization of Oenanthe species while defining critical boundaries regarding their toxicological risks.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


